p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies.
Saunthararajah Y, Triozzi P, Rini B, Singh A, Radivoyevitch T, Sekeres M, Advani A, Tiu R, Reu F, Kalaycio M, Copelan E, Hsi E, Lichtin A, Bolwell B.
Saunthararajah Y, et al. Among authors: hsi e.
Semin Oncol. 2012 Feb;39(1):97-108. doi: 10.1053/j.seminoncol.2011.11.011.
Semin Oncol. 2012.
PMID: 22289496
Free PMC article.
Review.